Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!  Twitter 
  Google+ 
Subscribe to our channel on YouTube!  YouTube  


Print  

FDA Approves Dosage of Pancreatic Enzyme Supplement ZENPEP® for Infants 

June 17, 2011

Aptalis Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new dosage of its pancreatic enzyme replacement therapy ZENPEP® (pancrelipase) formulated specifically for infants.

Earlier this week the FDA approved an infant-specific dosage of the pancreatic enzyme CREON®, made by Abbott Laboratories.

The lower-strength capsules allow for a more precise and consistent dose of pancreatic enzyme supplements to be given to infants with cystic fibrosis.  

Read more in the full release from Aptalis.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.